Decrease in mitochondrial function in rat cardiac permeabilized fibers correlates with the aging phenotype

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 65 A, Issue 11, 2010, Pages 1157-1164

  Lemieux, Hélne ^a,b   Vazquez, Edwin J ^a,b   Fujioka, Hisashi ^a,b   Hoppel, Charles L ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Aging; Mitochondrial; Oxidative phosphorylation; Rat; Strains

Indexed keywords

RATTUS;

CITRATE SYNTHASE;

AGING; ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; COMPARATIVE STUDY; ENZYMOLOGY; FISCHER 344 RAT; HEART MITOCHONDRION; MALE; METABOLISM; NONPARAMETRIC TEST; PHENOTYPE; PHYSIOLOGY; RAT;

AGING; ANALYSIS OF VARIANCE; ANIMALS; CITRATE (SI)-SYNTHASE; MALE; MITOCHONDRIA, HEART; PHENOTYPE; RATS; RATS, INBRED F344; STATISTICS, NONPARAMETRIC;

EID: 77958032255     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glq141     Document Type: Article

References (60)

1. Lakatta EG, Sollott SJ. The "heartbreak" of older age. Mol Interv. 2002;2:431-446.
2. Terman A, Brunk UT. Aging as a catabolic malfunction. Int J Biochem Cell Biol. 2004;36:2365-2375.
3. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation. 2003;107:139-146. (Pubitemid 36070946)
4. Lakatta E. Aging effects on the vasculature in health: risk factors for cardiovascular disease. Am J Geriatr Cardiol. 1994;3:11-17.
5. Barzilai N, Shuldiner AR. Searching for human longevity genes: the future history of gerontology in the post-genomic era. J Gerontol Med Sci. 2001;56:M83-M87.
6. Atzmon G, Schechter C, Greiner W, Davidson D, Rennert G, Barzilai N. Clinical phenotype of families with longevity. J Am Geriatr Soc. 2004; 52:274-277.
7. Perls TT, Wilmoth J, Levenson R, et al. Life-long sustained mortality advantage of siblings of centenarians. Proc Natl Acad Sci USA. 2002;99:8442-8447.
8. Weindruch R, Masoro E. Concerns about rodent models for aging research. J Gerontol. 1991;46:B87-B88.
9. Tanaka S, Shito A, Tamaya N, Miyaishi O, Nishimura M, Ohno T. Difference in average survival between F344/Du and F344/N rats is not due to genetic contamination. Arch Gerontol Geriatr. 2002;34:19-28.
10. Lipman RD, Chrisp CE, Hazzard DG, Bronson RT. Pathologic characterization of brown Norway, brown Norway x Fischer 344, and Fischer 344 x brown Norway rats with relation to age. J Gerontol Biol Sci. 1996;51:B54-B59.
11. Perls T, Terry D. Genetics of exceptional longevity. Exp Gerontol. 2003;38:725-730.
12. Partridge L, Gems D. Mechanisms of ageing: public or private? Nat Rev Genet. 2002;3:165-175.
13. Longo VD, Finch CE. Evolutionary medicine: from dwarf model systems to healthy centenarians? Science. 2003;299:1342-1346.
14. Friedman DB, Johnson TE. A mutation in the age-1 gene in Cae-norhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics. 1988;118:75-86.
15. Nakae J, Kitamura T, Silver DL, Accili D. The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest. 2001;108:1359-1367.
16. Ayala JE, Streeper RS, Desgrosellier JS, et al. Conservation of an insulin response unit between mouse and human glucose-6-phosphatase catalytic subunit gene promoters: transcription factor FKHR binds the insulin response sequence. Diabetes. 1999;48:1885-1889.
17. Durham SK, Suwanichkul A, Scheimann AO, et al. FKHR binds the insulin response element in the insulin-like growth factor binding protein-1 promoter. Endocrinology. 1999;140:3140-3146.
18. Hall RK, Yamasaki T, Kucera T, Waltner-Law M, O'Brien R, Granner DK. Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. The role of winged helix/forkhead proteins. J Biol Chem. 2000;275:30169-30175.
19. Nadal A, Marrero PF, Haro D. Down-regulation of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by insulin: the role of the forkhead transcription factor FKHRL1. Biochem J. 2002;366:289-297.
20. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev. 1998;78:547-581.
21. Fannin SW, Lesnefsky EJ, Slabe TJ, Hassan MO, Hoppel CL. Aging selectivity decreases oxidative capacity in rat heart interfbrillar mitochondria. Arch Biochem Biophys. 1999;372:399-407.
22. Lesnefsky EJ, Gudz TI, Moghaddas S, et al. Aging decreases electron transport complex III activity in heart interfbrillar mitochondria by alteration of the cytochrome c binding site. J Mol Cell Cardiol. 2001;33:37-47.
23. Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL. Mitochondrial dysfunction in cardiac disease: ischemia-reperfusion, aging, and heart failure. J Mol Cell Cardiol. 2001;33:1065-1089.
24. Moghaddas S, Hoppel CL, Lesnefsky EJ. Aging defect at the QO site of complex-III augments oxyradical production in rat heart interfbril-lar mitochondria. Arch Biochem Biophys. 2003;414:59-66.
25. Palmer JW, Tandler B, Hoppel CL. Biochemical properties of subsar-colemmal and interfbrillar mitochondria isolated from rat cardiac muscle. J Biol Chem. 1977;252:8731-8739.
26. Moghaddas S, Stoll MS, Mnkler PE, Salomon RG, Hoppel CL, Lesnefsky EJ. Preservation of cardiolipin content during aging in rat heart interfbrillar mitochondria. J Gerontol Biol Sci. 2002;57:B22-B28.
27. Lesnefsky EJ, He D, Moghaddas S, Hoppel CL. Reversal of mitochondrial defects before ischemia protects the aged heart. FASEB J. 2006;20:1543-1545.
28. Suh JH, Heath SH, Hagen TM. Two subpopulations of mitochondria in the aging rat heart display heterogenous levels of oxidative stress. Free Radic Biol Med. 2003;35:1064-1072.
29. Maeda H, Gleiser CA, Masoro EJ, Murata I, McMahan CA, Yu BP. Nutritional infuences on aging of Fischer 344 rats: II. Pathology. J Gerontol. 1985;40:671-688.
30. Kuznetsov AV, Schneeberger S, Seiler R, et al. Mitochondrial defects and heterogeneous cytochrome c release after cardiac cold ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 2004;286: H1633-H1641. (Pubitemid 38525448)
31. Veksler VI, Kuznetsov AV, Sharov VG, Kapelko VI, Saks VA. Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment by using saponin-skinned fbers. Biochim Biophys Acta. 1987;892:191-196.
32. Gnaiger E, Kuznetsov AV, Schneeberger S, et al. Mtochondria in the cold. In: Heldmaier G, Klingenspor M, eds. Life in the Cold. Heidelberg, Germany: Springer; 2000:431-442.
33. Gnaiger E. Polarographic oxygen sensors, the oxygraph and high-resolution respirometry to assess mitochondrial function. In: Dykens JA, Will Y, eds. Mitochondrial Dysfunction in Drug-Induced Toxicity. New York: John Wiley; 2008:327-352.
34. Gnaiger E, Lassnig B, Kuznetsov A, Reiger G, Margreiter R. Mitochondrial oxygen affnity, respiratory-fux control and excess capacity of cytochrome c oxidase. J Exp Biol. 1998;201:1129-1139.
35. Gnaiger E, Steinlechner-Maran R, Méndez G, Eberl T, Margreiter R. Control of mitochondrial and cellular respiration by oxygen. J Bioenerg Biomemb. 1995;27:583-596.
36. Matsuoka Y, Srere PA. Kinetic studies of citrate synthase from rat kidney and rat brain. J Biol Chem. 1973;248:8022-8030.
37. Kalt MR, Tandler B. A study of fxation of early amphibian embryos for electron microscopy. J Ultrastruct Res. 1971;36:633-645.
38. Karnovsky MJ. Use of ferrocyanide-reduced osmium tetroxide in electron microscopy. In: Proceedings of 11th Annual Meeting of the American Society of Cell Biology. November 15-17, 1971; New Orleans, LA. 146.
39. Tandler B. Improved uranyl acetate staining for electron microscopy. J Electron Microsc Tech. 1990;16:81-82.
40. Hanaichi T, Sato T, Iwamoto T, Malavasi-Yamashiro J, Hoshino M, Mizuno N. A stable lead by modifcation of Sato's method. J Electron Microsc. 1986;35:304-306.
41. Brand MD, Chien LF, Ainscow EK, Rolfe DF, Porter RK. The causes and functions of mitochondrial proton leak. Biochim Biophys Acta. 1994;1187:132-139.
42. Anversa P, Palackal T, Sonnenblick EH, Olivetti G, Meggs LG, Ca-passo JM. Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res. 1990;67:871-885.
43. Capasso JM, Fitzpatrick D, Anversa P. Cellular mechanisms of ventricular failure: myocyte kinetics and geometry with age. Am J Physiol. 1992;262:H1770-H1781.
44. Capasso JM, Palackal T, Olivetti G, Anversa P. Severe myocardial dysfunction induced by ventricular remodeling in aging rat hearts. Am J Physiol. 1990;259:H1086-H1096.
45. Anversa P, Hiler B, Ricci R, Guideri G, Olivetti G. Myocyte cell loss and myocyte hypertrophy in the aging rat heart. J Am Coll Cardiol. 1986;8:1441-1448.
46. Anversa P, Kajstura J, Olivetti G. Myocyte death in heart failure. Curr Opin Cardiol. 1996;11:245-251.
47. Riva A, Tandler B, Lesnefsky EJ, et al. Structure of cristae in cardiac mitochondria of aged rat. Mech Ageing Dev. 2006;127:917-921.
48. Paradies G, Ruggiero FM, Dinoi P, Petrosillo G, Quagliariello E. Decreased cytochrome oxidase activity and changes in phospholipids in heart mitochondria from hypothyroid rats. Arch Biochem Biophys. 1993;307:91-95. (Pubitemid 23333979)
49. Vik SB, Capaldi RA. Lipid requirements for cytochrome c oxidase activity. Biochemistry. 1977;16:5755-5759.
50. Hoch FL. Cardiolipins and biomembrane function. Biochim Biophys Acta. 1992;1113:71-133.
51. Powell GL, Knowles PF, Marsh D. Spin-label studies on the specifcity of interaction of cardiolipin with beef heart cytochrome oxidase. Biochemistry. 1987;26:8138-8145.
52. Gnaiger E. Capacity of oxidative phosphorylation in human skeletal muscle. New perspectives of mitochondrial physiology. Int J Biochem Cell Biol. 2009;41:1837-1845.
53. Lemieux H, Hoppel CL. Mtochondria in the human heart. J Bioenerg Biomembr. 2009;41:99-106.
54. Marin-Garcia J, Ananthakrishnan R, Goldenthal MJ. Human mitochondrial function during cardiac growth and development. Mol Cell Biochem. 1998;179(1-2):21-26.
55. Hacker TA, McKiernan SH, Douglas PS, Wanagat J, Aiken JM. Age-related changes in cardiac structure and function in Fischer 344 x Brown Norway hybrid rats. Am J Physiol Heart Circ Physiol. 2006;290: H304-H311.
56. Rice KM, Linderman JK, Kinnard RS, Blough ER. The Fischer 344/ NNiaHSd X Brown Norway/BiNia is a better model of sarcopenia than the Fischer 344/NNiaHSd: a comparative analysis of muscle mass and contractile properties in aging male rat models. Biogerontology. 2005;6:335-343.
57. Ventura-Clapier R, Mettauer B, Bigard X. Benefcial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure. Cardiovasc Res. 2007;73:10-18.
58. Ashrafan H, Frenneaux MP, Opie LH. Metabolic mechanisms in heart failure. Circulation. 2007;116:434-448.
59. Finck BN, Kelly DP. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation. 2007;115:2540-2548.
60. Rosca MG, Lemieux H, Hoppel CL. Mitochondria in the elderly: is acetylcarnitine a rejuvenator? Adv Drug Deliv Rev. 2009;61: 1332-1342.